Twist Bioscience stock falls despite Q4 beat and solid guidance
Investor's Business Daily reported that Twist Bioscience stock fell Thursday after the company posted better-than-expected fiscal fourth-quarter results. The post also states the company gave solid guidance.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Twist Bioscience stock dropped on Thursday after the company reported fiscal fourth-quarter metrics that beat expectations.
“Twist Bioscience stock took a header Thursday after the company reported better-than-expected fiscal fourth-quarter metrics”
Investor's Business Daily -
The company's guidance was described as solid.
“Twist Bioscience Crashes Despite Quarterly Beat, Solid Guidance”
Investor's Business Daily
Sources
More in Stocks & Indices
Embed this page
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-12 14:00 UTC. Labels are computed from the sources, not by the model.